Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

CEeDD: A phase I / II study to investigate the safety and feasibility of CavitationEnhanced Drug Delivery to solid tumours by co‐administration of sonosensitive particles and application of extracorporeal ultrasound

This study aims to determine whether low‐intensity, mobile extracorporeal ultrasound can be used to enhance the delivery, the distribution and ultimately  the therapeutic efficacy of unmodified small‐molecule and macromolecular oncology agents.

Our team

  • Sarah Pearson

    OCTO Trial Management Director